Eisner Mark
EVP and Chief Medical Officer at VIR; Officer at FGEN
- Sold, on record
- $721k
- Dollars the filings state
- Form 4 sales
- 8
- Latest Feb 25, 2026
- Form 144 notices
- 2
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale FGENNo planApr 4, 2023 2023
Sold 9,182 shares at $18.78 ($172k)
Eisner Mark, Chief Medical Officer
No 10b5-1 planSold 5.2% of holdings ($3.3M position)165,994 shares leftFiling
- 2 Form 144 notice FGENNoticeJun 2, 2023 +59 days
Filed to sell 1,090 shares ($21k)
Eisner Mark, Officer
No 10b5-1 plan0.1x usual sizeFiling
- 3 Form 4 sale FGENNo planJun 2, 2023 same day
Sold 1,090 shares at $18.83 ($21k)
Eisner Mark, EVP, Chief Medical Officer
No 10b5-1 planSold 0.7% of holdings ($3.1M position)164,904 shares left0.1x usual sizeFollows a Form 144Filing
- 4 Form 144 notice FGENNoticeJun 7, 2023 +5 days
Filed to sell 2,042 shares ($35k)
Eisner Mark, Officer
No 10b5-1 plan0.4x usual sizeFiling
- 5 Form 4 sale FGENNo planJun 7, 2023 same day
Sold 2,042 shares at $17.04 ($35k)
Eisner Mark, EVP, Chief Medical Officer
No 10b5-1 planSold 1.2% of holdings ($2.8M position)162,862 shares left0.4x usual sizeFollows a Form 144Filing
- 6 Form 4 sale VIRRoutineJul 17, 2025 +771 days
Sold 10,382 shares at $5.47 ($57k)
Eisner Mark, EVP and Chief Medical Officer
10b5-1 planSold 9% of holdings ($629k position)104,618 shares leftFirst sale on recordFiling
- 7 Form 4 sale VIRRoutineFeb 23, 2026 +221 days
Sold 2,089 shares at $7.45 ($16k)
Eisner Mark, EVP and Chief Medical Officer
10b5-1 planSold 1.3% of holdings ($1.2M position)157,529 shares leftFiling
- 8 Form 4 sale VIRRoutineFeb 25, 2026 +2 days
Sold 3,505 shares at $9.69 ($34k)
Eisner Mark, EVP and Chief Medical Officer
10b5-1 planSold 2.2% of holdings ($1.5M position)154,024 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (10)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | Feb 26, 2026 | VIR | EVP and Chief Medical Officer | Form 4 sale | 3,505 | $34k | 2.2% | Routine | SEC |
| Feb 23, 2026 | Feb 24, 2026 | VIR | EVP and Chief Medical Officer | Form 4 sale | 2,089 | $16k | 1.3% | Routine | SEC |
| Jul 17, 2025 | Jul 17, 2025 | VIR | EVP and Chief Medical Officer | Form 4 sale | 10,382 | $57k | 9.0% | Routine | SEC |
| Jun 7, 2023 | Jun 9, 2023 | FGEN | EVP, Chief Medical Officer | Form 4 sale | 2,042 | $35k | 1.2% | No plan | SEC |
| Jun 7, 2023 | Jun 7, 2023 | FGEN | Officer | Form 144 notice | 2,042 | $35k | Notice | SEC | |
| Jun 2, 2023 | Jun 5, 2023 | FGEN | EVP, Chief Medical Officer | Form 4 sale | 1,090 | $21k | 0.7% | No plan | SEC |
| Jun 2, 2023 | Jun 2, 2023 | FGEN | Officer | Form 144 notice | 1,090 | $21k | Notice | SEC | |
| Apr 4, 2023 | Apr 6, 2023 | FGEN | Chief Medical Officer | Form 4 sale | 9,182 | $172k | 5.2% | No plan | SEC |
| Mar 10, 2023 | Mar 10, 2023 | FGEN | Chief Medical Officer | Form 4 sale | 17,503 | $361k | 9.1% | Plan not stated | SEC |
| Mar 2, 2023 | Mar 6, 2023 | FGEN | Chief Medical Officer | Form 4 sale | 1,187 | $26k | 0.7% | Plan not stated | SEC |